All the benefits of expert nursing care
When key figures in European cancer nursing gathered at the Royal Marsden to mark 30 years of EONS, they found they had a lot to celebrate and a lot more work to do. All [more]
2014
Nutritional support for cancer patients
Patients who are receiving adequate nutrition have a better prognosis, respond better to chemotherapy and can tolerate higher doses of anticancer treatments. It is therefore important for oncologists to assess and manage malnutrition. Malnutrition, which [more]
To treat or not to treat: who should decide?
Shared decision making is ethically sound and the evidence shows it leads to better outcomes. But if a patient is determined that they want no part in the decision, is it paternalistic to insist? This [more]
Cancer control is (still) a vote winner
The Comprehensive Cancer Control Joint Action (CANCON) will pick up where the recently ended European Partnership for Action Against Cancer (EPAAC) left off. It will cover many of the same areas, but with a greater [more]
Enriqueta Felip: breaking boundaries in lung cancer
Building a lung cancer team that works seamlessly to do the best for each patient was the biggest challenge in Enriqueta Felips career. Her focus today is on increasing collaboration across Europe, which she sees [more]
Protecting patients’ nervous systems: Are we getting the care-cure balance right?
The debilitating impact neurotoxic drugs can have on patients long-term quality of life has been systematically underestimated. Can oncologists do more to pick up potential symptoms before they become irreversible? Cancer patients about to start [more]
The patient touts
Christiane Hawranek and Marco Maurer, freelance print and radio journalists, won a Best Cancer Reporter Award for their exposé of the agencies that exploit foreign patients seeking treatment for cancer and other serious conditions. They [more]
Living with cancer or dying of cancer?
People do better throughout their cancer journey when their physical, psychological and spiritual care needs are attended to. But how do we overcome entrenched mind sets that still resist integrating palliative and oncologic care? Philip [more]
What did we learn from the European Partnership for Action Against Cancer?
The recently concluded Partnership programme marked the first time that EU member states have taken a joint approach to improving cancer plans and the organisation of services. Was it a worthwhile exercise? And where do [more]
Top trials group turns its attention to survivors
EORTC boosts efforts to address the long-term problems faced by people who have been treated for cancer. The number of people who are living long lives after cancer treatment has been rising year on year, [more]
How Europe can develop better, cheaper cancer drugs
Modern tools of biological investigation give us opportunities to develop drugs much more efficiently. The president of Europes most important trials organisation explains how these opportunities can and must be exploited to start [more]
Smart therapeutic strategies in immuno-oncology
For cancer therapies to succeed, induction of an anticancer immune response is required. Immuno-oncology approaches are shaping the treatment landscape for patients with advanced-stage melanoma and other solid tumours. These new approaches may enhance immune [more]